Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported an increase in adjusted profit for the third quarter of 2025 when its revenues remained broadly unchanged year-over-year. The company also issued guidance for fiscal 2025.
Total revenues were $2.5 billion in the September quarter, compared to $2.47 billion last year. For the full year of 2025, the company expects revenues to be flat to up 1%, at constant currency, versus full year 2024.
Net income attributable to Biogen was $466.5 million or $3.17 per share in Q3, compared to $388.5 million or $2.66 per share in the third quarter of 2024. Adjusted earnings increased 18% annually to $4.81 per share in the third quarter.
The management said it expects full-year adjusted earnings per share to be in the range of $14.50 to $15.00, including expected improved business impact of approximately $0.25 EPS, offset by an expected impact in the fourth quarter from acquired IPR&D expenses.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%
Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues
AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted
Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to
